ArticleJournal for immunotherapy of cancer2022

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.

Rim Trad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.